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Abstract Chronic subdural haematoma (CSDH) is a
typical disease in elderly patients and encountered
frequently in neurosurgical practice. With an increasing
number of elderly people in the general population, there
is a need to investigate risk factors (age, falls, anticoag-
ulant or antithrombotic therapy) which could be pertinent
to the development of this disease. We reviewed 354
patients undergoing surgery for CSDH over a period of 7
years (1996–2002), the occurrence being equally distrib-
uted over these years. CSDH occurred more often in
elderly (≥65 years) than in younger people (69 vs 31%),
and in men than in women (64 vs 36%). Falls were
reported in 77% of patients. There was a trend towards a
higher risk of falls in the elderly. Antithrombotic or
anticoagulant therapy was present in 41% of patients, 32%
of them having had falls. Overall postoperative mortality
was 0% and overall recurrence rate 13.6%. CSDH in the
elderly population, especially in men, is frequently
associated with falls and anticoagulation or antithrombotic
therapy. The indication for these medications, especially in
elderly patients at risk for falls, should be carefully
evaluated and controlled.
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Introduction
Chronic subdural haematoma (CSDH) is a common
disease in neurosurgical practice. During the past 20
years burr hole followed by drainage or irrigation
craniostomy is the commonly performed procedure [16].
This surgical procedure can be carried out safely, also
under local anaesthesia. CSDH is predominantly a disease
of the elderly [13, 15]. In the year 2000, 21% of the
population in Basle was older than 65 years. For a variety
of reasons, the elderly are much more mobile and take part
in many leisure activities (Swiss speciality of picking
cherries leads to many falls). As the population is ageing,
we have to expect more cases of CSDH in the future. The
aim of this study was to find out if there is an increasing
incidence over the years, and to evaluate potential risk
factors (age, gender, falls and anticoagulation/antithrom-
botic therapy) that could play an essential role in the
development of CSDH.
Material and methods
We reviewed the charts of 354 consecutive patients with
CSDH operated in our neurosurgical department from
1996 to 2002. Diagnosis was based on computer tomo-
graphy scanning or magnetic resonance imaging. Surgical
treatment consisted of one or two burr hole craniostomies
and closed subdural drain for 48 h. Three potential risk
factors were assessed: gender, falls (defined as occurring 2
months or less before hospitalisation) and anticoagulation/
antithrombotic medication (warfarin, aspirin and its
derivatives).
Stata 7.0 software (Stata Corporation, TX, USA) was
used for statistical analysis. To describe frequency
distributions of age, gender, falls and number of patients
on anticoagulant or antithrombotic therapy we used the
one sample test of proportion. To identify risk factors for
the development of CSDH we calculated relative risk
ratios (RR) and corresponding 95% confidence intervals
(CI).
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Results
Patients’ age ranged from 2 to 94 years, with a mean of
68.3 years (SD±17.0). For this study patients were divided
into two groups: (1) younger than 65 years and (2) 65
years and older. The cases of CSDH were equally
distributed over the 7 years (Fig. 1). Postoperative
mortality was 0%.
Age
Age ≥65 years was associated with a higher incidence of
CSDH: 69% (n=245) of the patients were ≥65years,
whereas 31% (n=109) were younger (p<0.0001) (Table 1).
Gender
CSDH was seen more frequently in men than in woman
(64 vs 36%, p<0.0001). There was a significant male
preponderance in both elderly and younger patients
(Table 1). In patients younger than 65 years, 70% of
patients were men and 30% women (p<0.0001); in
patients 65 years and older, 62% were men and 38%
women (p<0.0001).
Falls
Two hundred seventy-two patients (77%) reported having
falls preceding CSDH. Men and women were equally
likely to have experienced a fall preceding the develop-
ment of CSDH (78 vs 75%, p>0.1). There was a trend
towards a higher risk of falls in elderly patients, but this
trend failed to reach statistical significance (RR 1.11, 95%
CI 0.96–1.27, p=0.12) (Fig. 2).
Anticoagulant and antithrombotic drug therapy
One hundred forty-four patients (41%) were taking
anticoagulant (20%) or antithrombotic (21%) drug therapy.
Elderly patients were significantly more likely to have
taken anticoagulant or antithrombotic therapy than young-
er patients (RR 1.75, 95% CI 1.24–2.49, p=0.0005). There
were no differences between men and women in the use of
this medication (Fig. 2). Of these 144 patients, 92 (64%)
had fresh haemorrhages in the CT with an onset of
symptoms only few days previously. One hundred and
fifteen patients (32%) had both preceding falls and were
taking anticoagulant or antithrombotic medication. There
were significantly more elderly than younger patients (85
vs 15%, p<0.0001, one sample test of proportion) and
significantly more men than women (66 vs 34%,
p<0.0001) having experienced falls while being on
anticoagulant or antithrombotic therapy (Fig. 2).
Figure 3 shows the age and gender distribution in
patients with falls who were on anticoagulant or anti-
thrombotic therapy. There is a peak in the number of cases
in the age group between 75 and 79 years.
Fig. 1 Annual incidence (1996–2002) of CSDH in 354 patients
operated in the Neurosurgical Clinic, Basle
Fig. 2 Risk factors for CSDH in 354 patients subdivided according
to age and gender and percentage of patients with each risk factor
Table 1 Age and gender distribution in 354 patients with chronic subdural haematoma operated in the Neurosurgical Clinic, Basle 1996–
2002
Patients, n (%) Gender (%) Age, n (%) Gender, age, n (%)
n=354 (100) range 2–94 years Male, 228 (64) <65 years, 109 (31) Male*, <65 years, 76 (21) female, <65 years, 33 (9)
Female, 126 (36) ≥65 years, 245 (69) Male*, ≥65 years, 152 (43) female, ≥65 years 93 (26)
*p<0.0001 vs female, Chi squared test
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Bilateral CSDH
Twenty-two percent of all CSDH were bilateral. There
were significantly more elderly than younger patients (86
vs 14%, p<0.0001), and more men than women with
bilateral CSDH (73 vs 27%, p<0.0001) (Fig. 4).
One hundred thirty-eight patients, 65 years and older
had one burr hole and 106 patients had two burr holes. The
corresponding numbers <65years are 72 and 38.
Recurrence
We defined recurrence as follows: in patients whose
symptoms failed to improve or got worse, a CT was
performed. If there was a recurrence of mass effect, a
further surgical intervention was carried out. Using these
criteria, the overall recurrence rate was 13.6% (n=48) and
was independent of the number of burr hole craniostomies
used at the time of the first neurosurgical intervention
(Fig. 5). Five patients needed a third operation. In total
four secondary craniostomies were performed. The
average time of the second intervention was about 4
weeks.
Discussion
As confirmed in our results, CSDH is a typical disease of
elderly patients [1, 6, 15]. Brain atrophy and decreasing
brain volume allow greater movements of the brain [6] and
older people also have a predisposition to trivial trauma.
These factors could also explain our finding that more
elderly patients have bilateral CSDH than younger ones
(Fig. 4).
We could show that there are almost twice as many men
with CSDH as women. This male preponderance has
already been described [13]. One study reports that male
preponderance diminishes with age [14]. This tendency
can be seen also in our results (2.3 times more men than
women in the younger group, 1.6 times in the older one
(Table 1)). One reason for male preponderance could be
that men have a greater exposure to injuries generally. In
medical practice multimorbidity in the elderly is found
more frequently in men than in women. Our study shows
that falls were associated with CSDH in 72% of the
patients, men and women being equally likely to report
falls (Fig. 2).
Our data demonstrate that of the patients with falls,
older patients reported significantly more use of anti-
thrombotic or anticoagulant medication than younger
patients. Therefore, a critical evaluation is needed in
elderly patients before antithrombotic or anticoagulant
therapy is initiated.
The outcome of patients with CSDH with coagulopathy
is often complicated with an increased recurrence rate,
which deserves attention [5]. The excess mortality
Fig. 5 Recurrence rate of CSDH and number of burr holes
Fig. 3 Peak incidence of falls and medication for males and females
at 75–79 years
Fig. 4 a,b Preponderance of elderly patients in monolateral and
bilateral CSDH
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associated with high international ratio (INR) supports the
use of less intensive treatment and more preventive action
to avoid episodes of high INR [9]. CSDH can mimic
transient ischemic attacks and should be excluded before
initiating anticoagulation therapy [18].
The risk of this therapy for causing haemorrhage should
not be underestimated. Already in 1992, Reymond et al.
reported that aspirin is a risk factor for haemorrhage in
patients with head injuries [12]. In contrast to other
surgical fields, aspirin could make neurosurgical proce-
dures impossible. Therefore, exact evaluation of coagula-
tion parameters is required before operation. In patients
with proved platelet dysfunction, surgical intervention in
our clinic was postponed if possible.
Before starting this study, we asked ourselves whether
the incidence of CSDH is increasing, because of wide-
spread prescribing of antithrombotic or anticoagulant
therapy. In our study the frequency of CSDH remained
stable over the years 1996–2002 (Fig. 1). However, the
number of patients with CSDH taking antithrombotic or
anticoagulant therapy may be higher than suggested by our
study; we had to extract information about antithrombotic
or anticoagulant therapy from charts where information
might have been incomplete. A lot of patients could not
remember their medication and forgot to mention
especially antithrombotic therapy, which they often took
to reduce headache or influenza symptoms.
In our study, the patients consisted of a selected
subgroup of all patients seen in the hospital with CSDH
since all our patients underwent surgical procedures. For
example, many patients with smaller CSDH who refused
an operation were not seen in our neurosurgical clinic.
Therefore, the findings of our study cannot be generalised
to patients not undergoing surgical therapy. There is one
prospective study with 43 elderly patients, which showed
that only patients with midline shift had a poor outcome
without surgery [4]. However, in that study the number of
patients was too small to draw general conclusions. In our
study, the postoperative mortality was 0% and the
recurrence rate was 13.6%, which is within the reported
range of 7.5–31% for burr hole craniostomies [3, 10, 11].
Interestingly, in the literature we cannot find an exact
definition of recurrence. In most cases diagnosis is made
clinically or radiologically.
Recurrence rate, complications and factors related to
these problems, especially in the elderly, are not
completely understood [7, 8] and have not improved
substantially over the past 20 years [16]. Therefore it is
important to reduce the risk factors in developing CSDH.
Another point of view is the new theory that CSDH might
be an angiogenic disease with specific patterns of growth
factors, which play a causative role in the pathogenesis of
CSDH [17]. This could offer new anti-angiogenetic
treatment options in the future.
Conclusions
The risk for surgically treated CSDH in the elderly
population especially in men, appears to be higher in
patients with falls and anticoagulation/antithrombotic
therapy. Therefore the indication for this medication
should be carefully evaluated and controlled, especially
in elderly patients with risk for falls. Further prospective
studies are needed to quantify the real incidence of CSDH
in combination with anticoagulation/antithrombotic med-
ication.
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